Jeremy VisserDec 21, 20231 minVIDEO: New AD guidelines published with updated treatments and recommendationsThe AAAAI/ACAAI JTF has published updated AD guidelines based on new available treatments and evidence-based recommendations.
Jeremy VisserDec 13, 20231 minVIDEO: Abrocitinib safe and efficacious in AD patients with or without allergic comorbiditiesAbrocitinib is efficacious and well tolerated in AD patients with or without allergic comorbidities.
Jeremy VisserNov 30, 20231 minVIDEO: Pruritus, pain are main drivers of AD impact and HRQoL, according to studyPain and pruritus are the main contributors to AD burden and poor health-related QoL.
Jeremy VisserNov 22, 20231 minVIDEO: Study shows PsO patients with pruritis, sleep disturbances experience lower QoL in all domainPsoriasis patients with pruritis and related sleep distrubances showed a lower quality of life in all domains.